The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
Frontiers in Pharmacology · 03.01.2025 · 15
DOI: 10.3389/fphar.2024.1505653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.01.2025. Verfasst von Changjing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cefoperazone/sulbactam (CPZ/SAM) is an important treatment option for infections caused by multidrug-resistant gram-negative bacteria. However, it is associated with an increased risk of coagulation disorders (CD) and causes severe bleeding in some instances. Early identification of risk factors and prediction of CD related to CPZ/SAM are crucial for prevention and treatment. This study aimed to explore the risk factors and developed a nomogram model for predicting the risk of coagulopathy in patients undergoing CPZ/SAM treatment.
Methods
A total of 1719 patients who underwent CPZ/SAM in the Affiliated Hospital of Southwest Medical University from August 2018 to August 2022, were recruited as the training cohort. For validation, 1,059 patients treated with CPZ/SAM from September 2022 to August 2024 were enrolled. Patients were divided into the CD and the N-CD groups. The occurrence of CD was designated as the dependent variable. The univariate and multivariate logistic regression analysis was performed to identify the risk factors of CD. A nomogram model was constructed from the multivariate logistic regression analysis and internally validated for model discrimination and calibration. The performance of the nomogram was estimated using the concordance index (C-index) and calibration curve.
Results
The multivariate logistic regression analysis resulted in the following independent risk factors for CD: baseline INR level (OR: 5.768, 95% CI: 0.484∼11.372, p = 0.036), nutritional risk (OR:2.711, 95%CI: 1.495∼4.125, p < 0.001), comorbidity of digestive system (OR:1.287, 95%CI: 0.434∼2.215, p = 0.004), poor food intake (OR:1.261, 95%CI: 0.145∼2.473, p = 0.032), ALB level (OR: −0.132, 95%CI: −0.229∼-0.044, p = 0.005) and GFR< 30 mL/min (OR: 1.925, 95%CI: 0.704∼3.337, p = 0.004). The internal validation confirmed the model’s good performance (C-index, 0.905 [95% CI: 0.864∼0.945]). The calibration plots in the nomogram model were of high quality. Validation further confirmed the reliability of the nomogram, with a C-index of 0.886 (95% CI: 0.832–0.940).
Conclusion
The nomogram model facilitated accurate prediction of CD in patients undergoing CPZ/SAM. And this could potentially contribute to reducing the incidence of CPZ/SAM-associated CD and consequently improving patients’ outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Vascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- School of pharmacy, Southwest Medical University, Luzhou, China.
Zitieren
APA
Xu, C., Zhu, J., Tu, K., Tang, H., Zhou, X., Li, Q., Chen, K., Yang, X., & Huang, Y. (2025). The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1505653
Vancouver
Xu C, Zhu J, Tu K, Tang H, Zhou X, Li Q, et al. The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model. Frontiers in Pharmacology. 2025;15. doi:10.3389/fphar.2024.1505653
BibTeX
@article{Xu2025,
author = {Xu, Changjing and Zhu, Junlong and Tu, Kun and Tang, Hui and Zhou, Xinxin and Li, Qiuyu and Chen, Kun and Yang, Xuping and Huang, Yilan},
title = {The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {15},
doi = {10.3389/fphar.2024.1505653}
}
EUVIMED